(Q48329275)

10 February 2018

editorial

0 references

title

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients? (English)

1 reference

10 February 2018

1 reference

1 reference

Steven De Vleeschouwer

series ordinal

2

1 reference

10 February 2018

author name string

Stefaan Van Gool

series ordinal

1

1 reference

10 February 2018

publication date

1 October 2012

1 reference

10 February 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

10 February 2018

volume

12

1 reference

10 February 2018

issue

10

1 reference

10 February 2018

page(s)

1173-1176

1 reference

10 February 2018

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Dendritic cell therapy of high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

DNA double-strand breaks: signaling, repair and the cancer connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.12.107

21 January 2018

Identifiers

DOI

10.1586/ERN.12.107

1 reference

10 February 2018

1 reference

10 February 2018